시장보고서
상품코드
1301478

세계의 인터보디 케이지 시장 : 시장 인사이트, 경쟁 구도, 시장 예측(2028년)

Interbody Cages - Market Insights, Competitive Landscape and Market Forecast-2028

발행일: | 리서치사: DelveInsight | 페이지 정보: 영문 150 Pages | 배송안내 : 2-10일 (영업일 기준)


※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 인터보디 케이지 시장 규모는 2023-2028년의 예측 기간 중 CAGR로 4.72%의 성장이 예측됩니다. 인터보디 케이지의 수요는 주로, 변성 퇴행성 추간판 질환(DDD), 척추고정술, 척추 손상 등 척추 질환의 증가에 의해 촉진되고 있습니다. 또한 첨단 혁신적인 기술의 채택 증가, 저침습수술의 수요 증가, 사고 건수의 증가, 제품 발매와 승인의 증가 등이 2023-2028년의 예측 기간 중 시장 전체의 성장에 기여하고 있습니다.

세계의 인터보디 케이지 시장에 대해 조사분석했으며, 시장 규모와 예측, 지역과 부문 분석, 기업 개요 등을 제공하고 있습니다.

목차

제1장 인터보디 케이지 시장 리포트의 서론

제2장 인터보디 케이지 시장의 주요 요약

  • 조사의 범위
  • 시장의 개요
  • 경쟁 평가

제3장 규제 분석

  • 미국
  • 유럽
  • 일본
  • 중국

제4장 인터보디 케이지 시장의 주요 요인 분석

  • 인터보디 케이지 시장 촉진요인
    • 척추 질환 유행
    • 다양한 치료 어프로치를 사용한 통증 경감과 삶의 질의 향상에 대한 환자의 수요 증가
    • 척추 질환 및 정형외과 질환에 걸리기 쉬운 고령 인구의 증가
  • 인터보디 케이지 시장 억제요인과 과제
    • 인터보디 케이지의 위치 차이 및 이동 등의 임플란트 관련 합병증
    • 미숙련 전문가의 이용 가능성
  • 인터보디 케이지 시장의 기회
    • 생분해성 인터보디 케이지나 3D 프린트 케이지 등 기술의 진보
    • 로봇 지원 인터보디 케이지 설치 시술의 채택

제5장 인터보디 케이지 시장 Porter's Five Forces 분석

제6장 인터보디 케이지 시장 레이아웃

  • 제품 유형별
    • 자궁경부 고정 기기
    • 흉부 고정 기기
    • 요추 고정 기기
  • 재료별
    • 티타늄
    • 폴리에테르에테르케톤(PEEK)
    • 기타
  • 최종사용자별
    • 병원
    • 외래 수술 센터
  • 지역별
    • 북미의 인터보디 케이지 시장 규모(2020-2028년)
    • 유럽의 인터보디 케이지 시장 규모(2020-2028년)
    • 아시아태평양의 인터보디 케이지 시장 규모(2020-2028년)
    • 기타 지역의 인터보디 케이지 시장 규모(2020-2028년)

제7장 인터보디 케이지 시장의 기업과 제품 개요

  • B. Braun SE
  • Ackermann Instrumente GmbH
  • Alphatec Spine Inc.
  • Eminent Spine
  • Medtronic plc
  • Zener Medtec
  • Rivarp Medical Private Limited
  • CarboFix Orthopedics Ltd
  • Intelivation LLC
  • Medacta International
  • Surgalign Spine Technologies
  • SeaSpine Orthopedics Corporation
  • Elite Surgical
  • Aurora Spine, Inc.
  • Zimmer Biomet
  • Globus Medical
  • Johnson & Johnson
  • Stryker
  • Ulrich Medical USA
  • Orthofix US LLC

제8장 KOL의 견해

제9장 프로젝트 어프로치

제10장 DelveInsight 소개

제11장 면책사항과 연락처

KSA 23.07.11

“Interbody Cages Market By Product Type (Cervical Fusion Device, Thoracic Fusion Device, And Lumbar Fusion Device), Material (Titanium, Poly-Ether-Ether-Ketone, And Others), End-User (Hospitals, Ambulatory Surgical Centers, And Others), and geography ” is expected to grow at a steady CAGR forecast till 2028 owing to the increasing figure of spinal injuries and the rising geriatric population prone to spinal disorders across the globe

The global interbody cages market is estimated to grow at a CAGR of 4.72% during the forecast period from 2023 to 2028. The demand for interbody cages is primarily being boosted by the increasing number of spinal disorders such as degenerative disc degeneration (DDD), spinal fusion, spinal injuries, and others. Further, the rising adoption of advanced and innovative technologies, the increasing demand for minimally invasive surgeries, the rising cases of accidents, and the increasing product launches & approval among others are thereby contributing to the overall growth of the interbody cages market during the forecast period from 2023-2028.

Interbody Cages Market Dynamics:

The interbody cages market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the figures of the geriatric population which are prone to spinal and orthopedic disorders.

According to the Government of India, Ministry of Statistics and Programme Implementation 2021, there were nearly 138 million elderly persons in India, 2021 comprising 67 million males and 71 million females.

According to World Health Organization (WHO) 2022, the number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion in 2030. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). In 2050, 80% of older people will be living in low- and middle-income countries. From the same source, in Japan 30% of the population is already over 60 years old.

The intervertebral discs in the spine naturally undergo degenerative changes with age. The discs lose hydration, become less flexible, and may experience wear and tear. These age-related degenerative changes can lead to disc herniation or collapse, requiring surgical intervention, which may need a fusion of the spinal cord. This fusion can be done by using interbody cages, which support the part of the spinal column. Thus, the demand for interbody cages is expected to grow in parallel with the aging population as elderly persons are more prone to spinal and orthopedic diseases.

Also, according to the Centers for Disease and Prevention Control (CDC) May 2022, in the US, each year, 36 million falls occur among older adults aged 65 and >65. One out of five falls causes a serious injury such as broken bones or a head injury.

Coupled with the factors mentioned above, strategic activities such as product launches & approvals, increasing research activities, and others will also contribute to the growth of the interbody cages market during the forecast period from 2023-2028. For instance, in January 2023, FDA approved the Eminent Spine 3D Cervical Interbody Fusion System by Eminent Spine. This system is indicated for intervertebral body fusion in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine at one disc level from the C2-C3 disc to the C7-T1 disc. Thus, the rising product launches and approval and the rising awareness among surgeons, healthcare professionals, and patients about the benefits of interbody cages will increase the demand for interbody cages during the forecast period.

Therefore, the aforementioned factors will propel the overall market growth of interbody cages during the forecast period from 2023-2028.

However, the availability of less skilled professionals, implant-related complications such as misplacement or migration of interbody cages, and others may restrict the interbody cages' market demand.

Interbody Cages Market Segment Analysis:

Interbody cages Market by Product Type (Cervical Fusion Device, Thoracic Fusion Device, and Lumbar Fusion Device), Material (Titanium, Poly-Ether-Ether-Ketone, and Others), End-User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the interbody cages, the lumbar fusion device category is expected to amass significant revenue share in the year 2022.

The growth expectations for different product types in the interbody cages market may vary based on various factors, including market trends, advancements in surgical techniques, and the prevalence of specific spinal conditions.

However, in recent years, the lumbar fusion device segment has generally been projected to exhibit significant growth because of the higher prevalence of lumbar spinal disorders such as degenerative disc disease (DDD), spondylolisthesis, and spinal stenosis, which are among the most common conditions affecting the lower back. These conditions often require surgical intervention, including lumbar fusion procedures. The high prevalence of lumbar spinal disorders drives the demand for lumbar fusion devices.

The increasing product launches and approvals will also create a positive impact on the demand for interbody cages which are specifically designed for lumbar spinal fusion during the forecast period from 2023-2028. For instance, in March 2020, FDA approved CarboClear Lumbar Cage System by CarboFix Orthopedics Ltd. This System is indicated for intervertebral body fusion of the lumbar spine in skeletally mature patients with degenerative disc disease (DDD). Thus, the increasing cases of product launches and approval among others may also increase the demand for lumbar fusion devices.

Therefore, the above-mentioned factor, product launches, and approvals are predicted to the increasing demand for this segment type. Hence, driving the growth of the interbody cages market during the forecast period.

North America is expected to dominate the overall Interbody Cages Market:

Among all the regions, North America is estimated to account for the largest share of the interbody cages market in the year 2022. Owing to the significance of key growth factors such as spinal cord injury due to accidents, sports, falls, violence, rising spinal disorders, and others are driving the North American interbody cages market and are expected to witness positive growth during the forecast period. Furthermore, the increasing product launches and approval, the increasing geriatric population in the region, the high disposable income, the sophisticated healthcare infrastructure, the rising regulatory approval for new products, and others will also help the market growth in this region.

According to Spinal Cord Association 2022, most spinal cord injuries happen as a result of a vehicle accident, followed closely by falls, trailed by violence, sports, and medical surgery.

According to the National Spinal Cord Injury Statistical Center 2020, the US population size of 329 million people, a recent estimate showed that the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the US, or about 17,810 new SCI cases each year. New SCI cases do not include those who die at the location of the incident that caused the SCI. Therefore, these increasing cases of spinal cord injury will need spinal fusion. Subsequently, the interbody cages needed to add extra support and strength to the fusion of the spinal cord, during the surgery. Hence, the increasing number of cases of spinal cord injury in North America will also increase the demand for interbody cages.

The rising product launches and approvals, mergers, acquisitions, partnerships, and others also help in boosting regional product demand. For instance, in August 2021, Alphatec Spine, Inc., a US-based company received FDA approval for PSX Interbody System. The PSX interbody system is indicated for spinal fusion procedures in skeletally mature patients at one or two contiguous levels in the lumbosacral spine (L1-L2 to L5-S1) for the treatment of degenerative disc disease (DDD). DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. Many such developments are taking place that includes product launches and approvals, and collaborations, that can boost the demand for interbody cages in North America. Thus, driving the North American interbody cages market forward during the forecast period.

Thus, the aforementioned factors would provide a growth environment for the North American region in the interbody cages market.

Interbody Cages Market Key Players:

Some of the key market players operating in the interbody cages market include B. Braun SE, Ackermann Instrumente GmbH, Alphatec Spine Inc., Eminent Spine, Medtronics, ZenerMed.com, Rivarp Medical Private Limited, CarboFix Orthopedics Ltd, Intelivation LLC, Medacta International, Surgalign Spine Technologies, SeaSpine Orthopedics Corporation, Elite surgical, Aurora Spine, Inc., Zimmer Biomet, Globus Medical, Johnson & Johnson, Stryker, Ulrich Medical USA, Orthofix US LLC, and others.

Recent Developmental Activities in the Interbody Cages Market:

  • In April 2021, Alphatec Spine, Inc. received FDA approval for IdentiTiTm ALIF Standalone Interbody System. The IdentiTi ALIF Standalone Interbody System is intended for use at one or two contiguous levels in the lumbar spine (L2-S1) for the treatment of DDD.
  • In December 2020, FDA approved WaveForm™ L Interbody System, WaveForm™ TO Interbody System, and WaveForm™ TA Interbody System by SeaSpine Orthopedics Corporation. The implants are manufactured from titanium alloy. SeaSpine WaveForm™ L System is indicated for use as an adjunct to fusion in skeletally mature patients with degenerative disc disease, defined as back pain of discogenic origin, with degeneration of the disc.

Key Takeaways from the Interbody Cages Market Report Study

  • Market size analysis for current interbody cages market size (2022), and market forecast for 5 years (2023-2028)
  • Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global interbody cages market.
  • Various opportunities are available for the other competitor in the interbody cages market space.
  • What are the top-performing segments in 2022? How these segments will perform in 2028.
  • Which are the top-performing regions and countries in the current interbody cages market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for interbody cages market growth in the coming future?

Target Audience who can be benefited from this Interbody Cages Market Report Study

  • Interbody cages products providers
  • Research organizations and consulting companies
  • Interbody cages-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in interbody cages
  • Various End-users who want to know more about the interbody cages market and the latest technological developments in the interbody cages market.

Frequently Asked Questions for the Interbody Cages Market:

1. What are interbody cages?

  • Interbody cages are cylindrical or crescent-shaped, hollow, and porous metallic devices that are placed between two adjacent vertebrae in a spinal segment after removing the damaged disc.

2. What is the market for global interbody cages?

  • The global interbody cages market is estimated to grow at a CAGR of 4.72% during the forecast period from 2023 to 2028.

3. What are the drivers for the global interbody cages market?

  • The demand for interbody cages is primarily being heightened by the increasing figure of spinal disorders such as DDD, spinal fractures, spinal deformities, and others. In addition, the rising adoption of advanced and innovative technologies, the increasing product launches & approval, and the rising cases of accidents among others are thereby contributing to the overall growth of the interbody cages market during the forecast period from 2023-2028.

4. Who are the key players operating in the global interbody cages market?

  • Some of the key market players operating in the interbody cages market include B. Braun SE, Ackermann Instrumente GmbH, Alphatec Spine Inc., Eminent Spine, Medtronics, ZenerMed.com, Rivarp Medical Private Limited, CarboFix Orthopedics Ltd, Intelivation LLC, Medacta International, Surgalign Spine Technologies, SeaSpine Orthopedics Corporation, Elite surgical, Aurora Spine, Inc., Zimmer Biomet, Globus Medical, Johnson & Johnson, Stryker, Ulrich Medical USA, Orthofix US LLC, and others.

5. Which region has the highest share in the interbody cages market?

  • North America is expected to dominate the overall interbody cages market during the forecast period from 2023-2028. Owing to the factors such as the rising prevalence of spinal disorders, the rising geriatric population in the region, and other factors will increase the North American interbody cages market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and others will also help the market growth in this region.

Table of Contents

1.Interbody Cages Market Report Introduction

2. Interbody Cages Market Executive Summary

  • 2.1. Scope of the Study
  • 2.2. Market at Glance
  • 2.3. Competitive Assessment

3. Regulatory Analysis

  • 3.1. The United States
  • 3.2. Europe
  • 3.3. Japan
  • 3.4. China

4. Interbody Cages Market Key Factors Analysis

  • 4.1. Interbody Cages Market Drivers
    • 4.1.1. Rising prevalence of the spinal disorders
    • 4.1.2. Increasing patient demand for pain relief and improved quality of life using different treatment approaches
    • 4.1.3. Increasing geriatric population prone to spinal and orthopedic disorders
  • 4.2. Interbody Cages Market Restraints and Challenges
    • 4.2.1. Implant-related complications such as misplacement or migration of interbody cage
    • 4.2.2. Availability of less skilled professionals
  • 4.3. Interbody Cages Market Opportunities
    • 4.3.1. Increasing technological advancements such as biodegradable interbody cages, and 3D-printed cages, among others
    • 4.3.2. The adoption of a robotic-assisted interbody cage placement procedure

5. Interbody Cages Market Porter's Five Forces Analysis

  • 5.1. Bargaining Power of Suppliers
  • 5.2. Bargaining Power of Consumers
  • 5.3. The threat of New Entrants
  • 5.4. Threat of Substitutes
  • 5.5. Competitive Rivalry

6. Interbody Cages Market Layout

  • 6.1. By Product Type
    • 6.1.1. Cervical Fusion Device
    • 6.1.2. Thoracic Fusion Device
    • 6.1.3. Lumbar Fusion Device
  • 6.2. By Material
    • 6.2.1. Titanium
    • 6.2.2. Poly-Ether-Ether-Ketone (PEEK)
    • 6.2.3. Others
  • 6.3. By End-User
    • 6.3.1. Hospitals
    • 6.3.2. Ambulatory Surgical Centers
    • 6.3.3. Others
  • 6.4. By Geography
    • 6.4.1. North American Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.1.1. United States Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.1.2. Canada Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.1.3. Mexico Interbody Cages Market Size in USD million (2020-2028)
    • 6.4.2. Europe Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.2.1. France Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.2.2. Germany Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.2.3. United Kingdom Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.2.4. Italy Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.2.5. Spain Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.2.6. Rest of Europe Interbody Cages Market Size in USD million (2020-2028)
    • 6.4.3. Asia-Pacific Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.3.1. China Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.3.2. Japan Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.3.3. India Interbody Cages Market Size in USD MILLION (2020-2028)
      • 6.4.3.4. Australia Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.3.5. South Korea Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.3.6. Rest of the Asia-Pacific Interbody Cages Market Size in USD million (2020-2028)
    • 6.4.4. Rest of the World (RoW) Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.4.1. Middle East Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.4.2. Africa Interbody Cages Market Size in USD million (2020-2028)
      • 6.4.4.3. South America Interbody Cages Market Size in USD million (2020-2028)

7. Interbody Cages Market Company and Product Profiles

  • 7.1. B. Braun SE
    • 7.1.1. Company Overview
    • 7.1.2. Company Snapshot
    • 7.1.3. Financial Overview
    • 7.1.4. Product Listing
    • 7.1.5. Entropy
  • 7.2. Ackermann Instrumente GmbH
    • 7.2.1. Company Overview
    • 7.2.2. Company Snapshot
    • 7.2.3. Financial Overview
    • 7.2.4. Product Listing
    • 7.2.5. Entropy
  • 7.3. Alphatec Spine Inc.
    • 7.3.1. Company Overview
    • 7.3.2. Company Snapshot
    • 7.3.3. Financial Overview
    • 7.3.4. Product Listing
    • 7.3.5. Entropy
  • 7.4. Eminent Spine
    • 7.4.1. Company Overview
    • 7.4.2. Company Snapshot
    • 7.4.3. Financial Overview
    • 7.4.4. Product Listing
    • 7.4.5. Entropy
  • 7.5. Medtronic plc
    • 7.5.1. Company Overview
    • 7.5.2. Company Snapshot
    • 7.5.3. Financial Overview
    • 7.5.4. Product Listing
    • 7.5.5. Entropy
  • 7.6. Zener Medtec
    • 7.6.1. Company Overview
    • 7.6.2. Company Snapshot
    • 7.6.3. Financial Overview
    • 7.6.4. Product Listing
    • 7.6.5. Entropy
  • 7.7. Rivarp Medical Private Limited
    • 7.7.1. Company Overview
    • 7.7.2. Company Snapshot
    • 7.7.3. Financial Overview
    • 7.7.4. Product Listing
    • 7.7.5. Entropy
  • 7.8. CarboFix Orthopedics Ltd
    • 7.8.1. Company Overview
    • 7.8.2. Company Snapshot
    • 7.8.3. Financial Overview
    • 7.8.4. Product Listing
    • 7.8.5. Entropy
  • 7.9. Intelivation LLC
    • 7.9.1. Company Overview
    • 7.9.2. Company Snapshot
    • 7.9.3. Financial Overview
    • 7.9.4. Product Listing
    • 7.9.5. Entropy
  • 7.10. Medacta International
    • 7.10.1. Company Overview
    • 7.10.2. Company Snapshot
    • 7.10.3. Financial Overview
    • 7.10.4. Product Listing
    • 7.10.5. Entropy
  • 7.11. Surgalign Spine Technologies
    • 7.11.1. Company Overview
    • 7.11.2. Company Snapshot
    • 7.11.3. Financial Overview
    • 7.11.4. Product Listing
    • 7.11.5. Entropy
  • 7.12. SeaSpine Orthopedics Corporation
    • 7.12.1. Company Overview
    • 7.12.2. Company Snapshot
    • 7.12.3. Financial Overview
    • 7.12.4. Product Listing
    • 7.12.5. Entropy
  • 7.13. Elite Surgical
    • 7.13.1. Company Overview
    • 7.13.2. Company Snapshot
    • 7.13.3. Financial Overview
    • 7.13.4. Product Listing
    • 7.13.5. Entropy
  • 7.14. Aurora Spine, Inc.
    • 7.14.1. Company Overview
    • 7.14.2. Company Snapshot
    • 7.14.3. Financial Overview
    • 7.14.4. Product Listing
    • 7.14.5. Entropy
  • 7.15. Zimmer Biomet
    • 7.15.1. Company Overview
    • 7.15.2. Company Snapshot
    • 7.15.3. Financial Overview
    • 7.15.4. Product Listing
    • 7.15.5. Entropy
  • 7.16. Globus Medical
    • 7.16.1. Company Overview
    • 7.16.2. Company Snapshot
    • 7.16.3. Financial Overview
    • 7.16.4. Product Listing
    • 7.16.5. Entropy
  • 7.17. Johnson & Johnson
    • 7.17.1. Company Overview
    • 7.17.2. Company Snapshot
    • 7.17.3. Financial Overview
    • 7.17.4. Product Listing
    • 7.17.5. Entropy
  • 7.18. Stryker
    • 7.18.1. Company Overview
    • 7.18.2. Company Snapshot
    • 7.18.3. Financial Overview
    • 7.18.4. Product Listing
    • 7.18.5. Entropy
  • 7.19. Ulrich Medical USA
    • 7.19.1. Company Overview
    • 7.19.2. Company Snapshot
    • 7.19.3. Financial Overview
    • 7.19.4. Product Listing
    • 7.19.5. Entropy
  • 7.20. Orthofix US LLC
    • 7.20.1. Company Overview
    • 7.20.2. Company Snapshot
    • 7.20.3. Financial Overview
    • 7.20.4. Product Listing
    • 7.20.5. Entropy

8. KOL Views

9. Project Approach

10. About DelveInsight

11. Disclaimer & Contact Us

비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제